Quercetin Market

Market Size (2026)
USD 479.7 Mn
Forecast (2036)
USD 696.5 Mn
CAGR (2026 to 2036)
3.8%

How Big Is the Quercetin Market in 2026?

The global quercetin market is valued at USD 479.7 million in 2026, up from USD 463.0 million in 2025, and is projected by Future Market Insights (FMI) to reach USD 696.5 million by 2036, expanding at a 3.8% CAGR to generate USD 216.8 million in incremental revenue over the forecast decade.

Table 1: Global Quercetin Market Size, Share, and Forecast Summary (2025 to 2036)
Market Metric Valuation / Share / Forecast Benchmark
2025 Market Size (Historical) USD 463.0 million
2026 Market Size (Estimated) USD 479.7 million
2036 Market Size (Projected) USD 696.5 million
Compound Annual Growth Rate (2026 to 2036) 3.8% CAGR
Incremental Dollar Opportunity (2026 to 2036) USD 216.8 million
Dominant Botanical Source (2026 Share) Sophora japonica Japanese Pagoda Tree Flower Buds (47.4% in 2026)
Dominant Chemical Formulation (2026 Share) Quercetin Dihydrate Crystalline Powder Above 95% (51.1% in 2026)
Dominant Health Target (2026 Share) Respiratory Allergy Mast Cell Histamine Stabilization (46.5% in 2026)
Dominant Delivery Format (2026 Share) Vegetarian Two-Piece Hard Capsules (44.2% in 2026)
Dominant Sales Channel (2026 Share) Direct to Nutraceutical and Supplement Brands (56.8% in 2026)
Largest Country Markets (2026 Global Share) United States (31.0%), Germany (10.0%), United Kingdom (6.5%), France (5.0%)
Fastest-Growing Country Markets (2026 to 2036) Mexico (4.6% CAGR), United States (4.3% CAGR), Germany (4.1% CAGR)
Leading Tier-1 Companies Indena S.p.A., Layn Natural Ingredients, Sabinsa Corporation, San-Ei Gen F.F.I., Ashland Inc., Givaudan SA

Source: Future Market Insights analysis of the quercetin market, 2026.

Quercetin Market Projected Values
Quercetin Market Projected Values

Executive Market Overview

Consumer and practitioner adoption of standardized quercetin across respiratory wellness and healthy-aging formulations is expanding as buyers incorporate plant polyphenols into daily preventive regimens. FMI finds that Sophora japonica Japanese Pagoda Tree Flower Buds account for 47.4% of botanical source revenue in 2026, while Respiratory Allergy Mast Cell Histamine Stabilization leads health target demand at 46.5% share. Clinical cohort trials published in Frontiers in Nutrition (February 2025) demonstrated that daily supplementation supplying 400 mg/day active quercetin delivered as 1,000 mg/day Quercetin Phytosome reduced serum uric acid by 13.1% to 15.2% and triglycerides by 10.2% to 20.8% after 90 days, accelerating year-round retail turnover beyond spring allergy windows across North America and Europe.

Standard unformulated crystalline quercetin aglycone suffers from poor water solubility and low intestinal absorption, forcing supplement finishers to use high 500 mg capsule dosages at narrow retail gross margins. To lift revenue per kilogram, phytochemical manufacturers are commercializing phospholipid complexes (Phytosomes) and enzymatically modified isoquercitrin (EMIQ) that dissolve cleanly into ready-to-mix sports recovery stick packs and functional waters. FMI projects the quercetin market to advance at a 3.8% CAGR through 2036 within the broader flavonoid ingredients category, driven by high-absorption delivery formats. Market sizing covers purified quercetin dihydrate, anhydrous quercetin, phytosome complexes, and water-soluble EMIQ, while excluding unhydrolyzed bulk rutin, unstandardized fruit powders, and raw citrus peel extracts.

Analyst Perspective

"Quercetin revenue growth through 2036 will split between volume-driven 95% Sophora japonica dihydrate crystals for mass-market vitamin C allergy combinations and high-margin phospholipid or EMIQ glycosylated complexes for practitioner senolytic and sports-recovery lines. The chief commercial risk is spot price compression in standard dihydrate drums whenever Chinese pagoda-bud harvests exceed seasonal immunity demand."

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights (FMI)

Major Market Trends and Insights

  • Green Extraction and Pulsed-Electric-Field Pretreatment Unlock Upcycled Onion-Skin Supply: Nutraceutical and clean-label food developers formulating with natural antioxidants are evaluating upcycled Allium cepa (yellow onion) skins alongside Sophora japonica buds to substantiate European and North American agricultural circularity claims. A synthesis of 83 studies published in Molecules (August 2026) documented that pulsed-electric-field pretreatment raised onion-skin quercetin recovery by 33.22% to 19.25 mg/g dry skin while liquid-liquid isolation achieved 93% purity with 600-fold lower solvent consumption, enabling meat and edible-oil processors to retard lipid peroxidation without synthetic additives.
  • Tightening Global Pharmacopeial Contaminant Standards Accelerate cGMP Refinery Consolidation: Multinational supplement brands actively audit botanical raw-material chains to confirm that dried Sophora japonica flower buds and onion skins comply with strict polycyclic aromatic hydrocarbon (PAH), heavy-metal, and residual-solvent thresholds. International regulatory benchmarks published by the World Health Organization (October 2025) in its Global traditional medicine strategy 2025-2034 reinforce harmonized pharmacopeial identity and contaminant testing across traded herbal actives, accelerating buyer migration toward botanical extracts manufacturers operating closed-loop deionized water crystallization and batch-level HPTLC/HPLC verification.
  • Phospholipid Phytosome Dispersion Enables Compact Single-Capsule Senolytic Longevity Stacks: Healthy-aging and cellular-longevity brands are formulating bioavailable quercetin as a daily senolytic agent that clears senescent cells and dampens chronic inflammaging alongside NAD+ precursors, fisetin, and resveratrol. Technical documentation from Indena S.p.A. (December 2025) confirms that dispersing Sophora japonica quercetin into a food-grade sunflower-lecithin Phytosome matrix delivers up to 20-fold higher human plasma bioabsorption than unformulated quercetin aglycone, allowing dietary supplements marketers to replace bulky 1,000 mg regimens with a single 250 mg vegetarian capsule.

What Are the Main Drivers, Restraints, and Opportunities?

Year-round consumer adoption of mast-cell allergy, vascular endothelial, and metabolic uric-acid supplements drives sales of quercetin flavonols, whereas hydrophobic crystal precipitation and enterocyte conjugation restrain unformulated beverage and gummy efficacy, positioning water-soluble EMIQ and phospholipid complexes as the primary margin expansion opportunity.

Driver: Multi-Target Clinical Adoption Across Vascular Endothelial, Uric-Acid, and Senolytic Regimens

Preventive cardiovascular and metabolic wellness buyers increasingly add bioavailable quercetin to daily routines to protect endothelial nitric oxide signaling and inhibit xanthine oxidase when paired with turmeric curcumin extract co-formulations. Cerebrovascular research published in Frontiers in Nutrition (February 2026) reported that enzymatic modification of isoquercitrin elevates peak plasma concentrations up to 40-fold with a 15-minute Tmax while liposomal encapsulation raises bioavailability 50-fold at one-fifth the conventional dose. A February 2025 observational study of three cohorts in Frontiers in Nutrition reported 13.1% to 15.2% serum uric-acid reductions and 10.2% to 20.8% triglyceride reductions after 90 days of supplementation supplying 400 mg/day quercetin delivered as 1,000 mg/day Quercetin Phytosome.  

Restraint: Severe Hydrophobic Crystal Stacking and Rapid Enterocyte Glucuronidation

High crystallinity and lipophilicity of native quercetin aglycone create formulation hurdles whenever beverage, effervescent, and gummy manufacturers attempt to expand beyond hard-shell capsules. Unmodified quercetin precipitates in aqueous matrices, stains teeth yellow, and undergoes rapid phase-II sulfation and glucuronidation in the small intestine, capping systemic plasma exposure unless brands procure encapsulated grades paired with botanical CO2 extracts. Pharmacokinetic evaluations published in Molecules (July 2025) demonstrated that co-crystallizing quercetin with nicotinamide raised plasma concentrations by 392% and rice-bran protein nanoemulsions lifted bioavailability 9-fold, underscoring the delivery cost barrier facing price-sensitive retail supplement lines.

Opportunity: Water-Soluble Glycosylated EMIQ, Functional Beverage Powders, and Longevity Blends

Formulating water-soluble, alpha-glycosylated quercetin (EMIQ) and sunflower-lecithin phytosomes allows functional beverage and sports nutrition brands to eliminate chalky sedimentation and unlock rapid 15-minute cellular absorption. Retail scanner tracking from the Natural Products Association (NPA, November 2025) confirms that clean-dissolving flavonol drink sticks and sparkling immunity waters command a 30.0% to 45.0% price premium over standard tablet bottles. Ingredient developers are converting water-insoluble Sophora japonica rutin into FDA GRAS alpha-glycosyl isoquercitrin that dissolves completely in cold liquids without cloudiness. Commercial trade exhibits, led by Indena S.p.A. (October 2026) at SupplySide Global, translate these delivery advantages into multi-year active nutrition supply agreements.

How Is the Quercetin Market Segmented?

The global quercetin market is segmented by botanical source, chemical formulation, health target, delivery format, sales channel, and region, with all commercial grades standardized on an active quercetin flavonol weight basis.

Table 2: Global Quercetin Market Segmentation Architecture and Forecast Benchmarks
Segmentation Axis Sub-Segments Covered 2026 Leading Segment & Share Main Growth Benchmark (2026 to 2036)
Botanical Source Sophora japonica Japanese Pagoda Tree Flower Buds, Yellow Onion Allium cepa Skins, Apple Fruit Peels, Dimorphandra mollis Fava d'Anta Pods Sophora japonica Flower Buds (47.4% revenue share) High 15% to 25% native rutin titer for clean acid hydrolysis at 3.8% global CAGR
Chemical Formulation Quercetin Dihydrate Crystalline Powder Above 95%, Quercetin Phytosome Phospholipid Complex Liposomal, Enzymatically Modified Isoquercitrin EMIQ, Water-Dispersible Cyclodextrin Inclusion Complexes Quercetin Dihydrate Crystalline Powder Above 95% (51.1% revenue share) USP dietary supplement monograph compliance and 36-month ambient stability
Health Target Respiratory Allergy Mast Cell Histamine Stabilization, Immune Defense and Cellular Senolytic Formulations, Cardiovascular Endothelial Blood Pressure Support, Sports Endurance Athletic Performance, Metabolic Uric Acid and Glycemic Support Respiratory Allergy Mast Cell Stabilization (46.5% revenue share) Non-drowsy seasonal pollen and sinus capsule repeat purchasing
Delivery Format Vegetarian Two-Piece Hard Capsules, Compressed Sustained-Release Tablets, Effervescent and Functional Beverage Powders, Pectin Gummies and Liquid Emulsions Vegetarian Two-Piece Hard Capsules (44.2% revenue share) Hypromellose shells mask astringent flavonol bitterness without wet-granulation heat
Sales Channel Direct to Nutraceutical and Supplement Brands, Specialty Botanical Ingredient Distributors, Contract Nutraceutical Co-Packers, B2B Digital Ingredient Marketplaces Direct to Nutraceutical and Supplement Brands (56.8% sales share) Clinical phytosome trademark licensing and direct Sophora harvest contracts
Region North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East & Africa North America & Western Europe (US at 31.0% and Germany at 10.0% global share) Mexico (4.6% CAGR) and United States (4.3% CAGR) lead national expansion

Source: Future Market Insights analysis of the quercetin market, 2026.

Why Do Sophora japonica Japanese Pagoda Tree Flower Buds Lead by Botanical Source?

Quercetin Market Breakdown Botanical Source
Quercetin Market Breakdown Botanical Source

Sophora japonica (Japanese pagoda tree) flower buds account for a leading 47.4% share of botanical source demand in 2026, supported by superior raw rutin concentration and established cGMP hydrolysis infrastructure across China, Vietnam, and India. Unopened dried flower buds contain 15% to 25% rutin by dry weight, enabling extraction refineries to cleave the rhamnoglucoside sugar via aqueous acid hydrolysis and crystallize 95% to 98% pure quercetin dihydrate at commercial yield. Upcycled yellow onion (Allium cepa) skins and apple peels attract premium circular-economy sports nutrition brands, yet their lower 1% to 3% native flavonol titer requires higher solvent and chromatographic cleanup volumes. Translational research maintained by the National Center for Biotechnology Information in Biomedicines (May 2026) confirmed that oral Sophora japonica quercetin regimens between 200 and 1,000 mg/day suppress Col1A1 fibrotic pathways and achieve over 10-fold higher bioabsorption when formulated into phospholipid phytosomes.

What Sustains Quercetin Dihydrate Crystalline Powder Above 95% Leadership by Chemical Formulation?

Quercetin Dihydrate Crystalline Powder Above 95% represents 51.1% of the chemical formulation segment in 2026, serving as the workhorse specification for bulk vitamin C immunity tablets, zinc ionophore capsules, and bromelain seasonal sinus combinations. Contract tablet presses and high-volume encapsulators favor 95% to 98% HPLC-verified dihydrate crystals for their low cost per gram, USP dietary supplement monograph standardization, and 36-month ambient warehouse stability. At the same time, brand owners formulating premium nutraceutical gummies and single-capsule longevity SKUs are trading up to phospholipid-complexed and glycosylated grades: technical specifications published by Indena S.p.A. (July 2026) for QUERCEFIT document that Sophora japonica quercetin standardized to 34.0% to 42.0% HPLC assay in sunflower lecithin optimizes human plasma absorption up to 20-fold at a 250 mg once- or twice-daily dose.

How Does Respiratory Allergy Mast Cell Histamine Stabilization Lead by Health Target?

Respiratory Allergy Mast Cell Histamine Stabilization captures 46.5% of global health target revenue in 2026, driven by recurring spring and autumn consumer purchases of non-sedating sinus and pollen support capsules. Quercetin stabilizes mucosal mast-cell membranes and inhibits calcium-dependent histamine, leukotriene, and prostaglandin degranulation without the central nervous system drowsiness associated with first-generation synthetic antihistamines, making quercetin-bromelain stacks a staple across retail herbal supplements aisles. Meanwhile, metabolic and senolytic indications represent the fastest-growing secondary targets: a systematic review published in Frontiers in Endocrinology (April 2026) across nine metabolic disorders documented that oral quercetin undergoes phase-II glucuronidation and sulfation with peak plasma metabolites at 0.6 to 0.8 hours and attenuates hepatic steatosis, hyperuricemia, and glycemic fluctuations.

Why Do Vegetarian Two-Piece Hard Capsules Lead by Delivery Format?

Vegetarian Two-Piece Hard Capsules secure 44.2% of delivery format demand in 2026, supported by clean-label hypromellose (HPMC) shells that mask the astringent bitterness and bright yellow staining of concentrated flavonol powders. Unlike compressed tablets that require wet-granulation binders and high compression forces, or ready-to-drink emulsions that require hydrocolloid suspension agents to prevent crystal sedimentation, two-piece vegetarian capsules run at high rotary filling speeds with minimal excipient overhead. Advanced delivery technology is simultaneously expanding capsule adoption: formulation studies published in Frontiers in Pharmacology (February 2026) demonstrated that natural chitosan encapsulation achieves 90.5% quercetin loading efficiency while improving gastrointestinal absorption, allowing nutraceutical contract packagers to market high-bioavailability joint-health and vascular supplements at premium price points.

What Gives Direct to Nutraceutical and Supplement Brands the Largest Share by Sales Channel?

Direct to Nutraceutical and Supplement Brands commands 56.8% of global sales channel revenue in 2026, anchored by multi-ton annual supply agreements, clinical trademark co-branding (QUERCEFIT, EMIQ, Quercevital), and direct cGMP refinery audits. National supplement brand owners and practitioner nutraceutical houses contract directly with primary extractors to specify particle-size distributions (80-mesh standard versus 200-mesh micronized powders) and verify zero synthetic adulteration or unreacted rutin carryover above 2.0%. Direct processor partnerships also support upcycled agricultural raw-material valorization: feed and ingredient processing trials published in Applied Sciences (July 2025) confirmed that thermal-mechanical expansion and pelleting of Allium cepa onion peel waste at a 3% inclusion rate delivered 75 mg/day of stable quercetin while reducing volatile onion aroma intensity.

Quercetin Market by Region and Country (2026 to 2036)

Quercetin Market Dashboard
Quercetin Market Dashboard

North America and Western Europe represent the primary revenue centers for standardized and bio-enhanced quercetin, while Latin American pharmacy markets post the highest percentage growth rates through 2036. FMI demand projections show that the eight tracked core countries below account for 67.5% of global revenue in 2026 (USD 323.9 million) and 69.6% by 2036 (USD 485.0 million). The United States leads global consumption at 31.0% share in 2026 (USD 148.7 million), adding USD 77.9 million over the decade (35.9% of total global incremental growth) to reach USD 226.6 million by 2036 (4.3% CAGR). At the same time, Mexico records the fastest national growth rate at a 4.6% CAGR, expanding from USD 14.4 million in 2026 to USD 22.6 million by 2036 as urban pharmacy chains scale respiratory and metabolic combination capsules.

Table 3: Quercetin Market Size, 10-Year Revenue Addition, Global Share, and CAGR by Country (2026 to 2036)

Country

2026 Revenue

2036 Revenue

10-Year Addition

2026 to 2036 CAGR

Global Share (2026 → 2036)

United States

USD 148.7 million

USD 226.6 million

+USD 77.9 million

4.3%

31.0% → 32.5%

Germany

USD 48.0 million

USD 71.7 million

+USD 23.7 million

4.1%

10.0% → 10.3%

United Kingdom

USD 31.2 million

USD 46.2 million

+USD 15.0 million

4.0%

6.5% → 6.6%

France

USD 24.0 million

USD 34.2 million

+USD 10.2 million

3.6%

5.0% → 4.9%

Canada

USD 21.6 million

USD 31.1 million

+USD 9.5 million

3.7%

4.5% → 4.5%

Brazil

USD 19.2 million

USD 28.2 million

+USD 9.0 million

3.9%

4.0% → 4.0%

Spain

USD 16.8 million

USD 24.4 million

+USD 7.6 million

3.8%

3.5% → 3.5%

Mexico

USD 14.4 million

USD 22.6 million

+USD 8.2 million

4.6%

3.0% → 3.2%

Source: Future Market Insights analysis of the quercetin market, 2026.

United States

The United States is the largest national quercetin market globally, with revenue projected by FMI to expand at a 4.3% CAGR from USD 148.7 million in 2026 to USD 226.6 million by 2036, adding USD 77.9 million in 10-year revenue and lifting its global share from 31.0% to 32.5%. American supplement brand owners and practitioner nutraceutical lines formulate standardized 95% quercetin dihydrate and sunflower-lecithin phytosomes into year-round sinus support capsules and cellular senolytic stacks. Commercial rollouts by Indena S.p.A. (October 2026) at SupplySide Global 2026 in Las Vegas highlighted QUERCEFIT Golden Aging longevity positioning, while computational and metabolic target analysis in Chemistry Proceedings (November 2025) substantiated quercetin combination regimens for glycemic balance. Expanding U.S. retail adoption of single-capsule senolytic and water-soluble EMIQ hydration sticks is projected to drive sustained contract manufacturing growth through 2036.

Germany

Germany is the second-largest national market and anchors Western European demand, forecast to grow at a 4.1% CAGR from USD 48.0 million in 2026 to USD 71.7 million by 2036, generating USD 23.7 million in incremental revenue and raising its global share from 10.0% to 10.3%. FMI finds that German pharmacies (Apotheken) and phytopharmaceutical formulators prioritize pharmacopeial-grade Sophora japonica quercetin tested for strict polycyclic aromatic hydrocarbon (PAH4) and heavy-metal compliance. Preclinical neuroprotection research published in Frontiers in Pharmacology (June 2026) documented quercetin's multitarget vascular and antioxidant mechanisms against cerebral ischemia-reperfusion injury, while the World Health Organization (October 2025) Global traditional medicine strategy 2025-2034 reinforced harmonized European herbal quality standards. Rising demand for clinically substantiated vascular and healthy-aging flavonols among German pharmacy buyers is expected to sustain steady annual order expansion through 2036.

United Kingdom

In the United Kingdom, quercetin sales are projected to advance at a 4.0% CAGR from USD 31.2 million in 2026 to USD 46.2 million by 2036, delivering USD 15.0 million in 10-year incremental revenue and moving its global share from 6.5% to 6.6%. FMI believes British health-food chains and direct-to-consumer supplement brands drive volume by pairing standardized quercetin dihydrate with vitamin C and bromelain for non-drowsy seasonal pollen relief. Country market records from the USDA Foreign Agricultural Service (March 2026) in United Kingdom: Food Processing Ingredients Annual (Report UK2026-0008) confirm resilient UK processor demand for clean-label functional botanicals, complemented by Indena S.p.A. (November 2025) presenting QUERCEFIT healthy-aging solutions to European formulators. Broadening UK supermarket and pharmacy shelf space for bioavailable immunity gummies and effervescent powders is forecast to support steady revenue growth through 2036.

France

France is forecast by FMI to progress at a 3.6% CAGR from USD 24.0 million in 2026 to USD 34.2 million by 2036, adding USD 10.2 million in 10-year revenue while holding a global share of 5.0% in 2026 (4.9% in 2036). French parapharmacy supplement houses and dermo-cosmetic laboratories use high-purity quercetin dihydrate and upcycled onion polyphenols in capillary-support capsules and anti-photoaging skincare serums. Official sector data from the USDA Foreign Agricultural Service (April 2026) in France: Food Processing Ingredients Annual (Report FR2026-0003) document steady French botanical processing output, while Arjuna Natural Pvt. Ltd. (June 2026) showcased clinically researched flavonoid extracts at Nutriform Business Days 2026 in France. Growing dermatological and parapharmacy adoption of oral-and-topical antioxidant regimens is projected to maintain high-value French batch orders through 2036.

Canada

In Canada, quercetin revenue is projected to expand at a 3.7% CAGR from USD 21.6 million in 2026 to USD 31.1 million by 2036, generating USD 9.5 million in 10-year incremental value and maintaining a 4.5% global revenue share. In FMI's view, Canadian natural health product marketers procure HPLC-verified Sophora japonica quercetin dihydrate to formulate Health Canada Natural Product Number (NPN) licensed seasonal allergy and cardiovascular support capsules. Trade reporting from the USDA Foreign Agricultural Service (August 2026) in Canada: Food Processing Ingredients Annual (Report CA2026-0022) highlights sustained Canadian manufacturing demand for certified botanical actives across Ontario and British Columbia co-packers. Strict federal monograph verification and repeat consumer purchasing of licensed non-drowsy allergy supplements are expected to anchor dependable Canadian wholesale growth through 2036.

Brazil

Brazil is projected to grow at a 3.9% CAGR from USD 19.2 million in 2026 to USD 28.2 million by 2036, contributing USD 9.0 million in 10-year revenue addition while holding a stable 4.0% share of global revenue. FMI observes that Brazilian compounding pharmacies (farmacias de manipulacao) and sports-nutrition brands across Sao Paulo dispense micronized quercetin capsules and recovery drink powders to reduce post-exercise oxidative stress. Sector analysis from the USDA Foreign Agricultural Service (March 2026) in Brazil: Food Processing Ingredients Annual (Report BR2026-0011) confirms expanding Brazilian imports of specialized nutraceutical and antioxidant ingredients across domestic finishing plants. Rising urban participation in endurance sports and preventative metabolic supplementation is forecast to sustain consistent Brazilian volume expansion through 2036.

Spain

Spain is forecast to advance at a 3.8% CAGR from USD 16.8 million in 2026 to USD 24.4 million by 2036, adding USD 7.6 million in 10-year revenue and maintaining a 3.5% global share across the decade. Spanish herbal parapharmacies and contract nutraceutical packagers in Catalonia and Madrid formulate Sophora japonica quercetin with citrus bioflavonoids for seasonal respiratory comfort and venous microcirculation support. Country documentation from the USDA Foreign Agricultural Service (March 2026) in Spain: Food Processing Ingredients Annual (Report SP2026-0003) confirms expanding Iberian food and supplement processor adoption of plant-derived antioxidants. Growing consumer preference for clean-label Mediterranean vascular and allergy supplements is projected to support steady Spanish distributor orders through 2036.

Mexico

Mexico posts the fastest national growth rate among all tracked countries at a 4.6% CAGR, rising from USD 14.4 million in 2026 to USD 22.6 million by 2036, adding USD 8.2 million over the forecast decade and lifting its global share from 3.0% to 3.2%. FMI notes that Mexican pharmacy chains and nutritional co-packers in Mexico City and Guadalajara are expanding quercetin combination SKUs targeting urban respiratory allergy relief and metabolic uric-acid management. Trade assessments from the USDA Foreign Agricultural Service (April 2026) in Mexico: Food Processing Ingredients Annual (Report MX2026-0022) document rising Mexican imports of standardized botanical extracts, while Givaudan SA (July 2026) reported CHF 3,799 million in first-half 2026 group sales while expanding regional Taste & Wellbeing botanical capacity in Mexico. Retail pharmacy proliferation of preventive immunity and metabolic capsules is projected to drive rapid Mexican revenue growth through 2036.

Competitive Environment and Notable Companies

Quercetin Market Company Share
Quercetin Market Company Share

Notable companies operating in the global quercetin market include Indena S.p.A., Layn Natural Ingredients, Sabinsa Corporation, San-Ei Gen F.F.I., Ashland Inc., Givaudan SA, International Flavors & Fragrances Inc. (IFF), Kemin Industries, Arjuna Natural Pvt. Ltd., and Botanic Healthcare. Competition divides into three functional groups: proprietary bioavailability and clinical delivery innovators engineering phospholipid phytosomes and glycosylated isoquercitrin; vertically integrated Asian and Indian botanical extractors refining Sophora japonica flower buds into 95% to 98% dihydrate crystals; and multinational flavor, nutrition, and shelf-life groups supplying clean-label polyphenol systems.

How Are Companies Positioned in the Quercetin Market?

The premium bioavailable delivery tier is led by Indena S.p.A. (October 2026) with QUERCEFIT (Quercetin Indena Phytosome), San-Ei Gen F.F.I. with FDA GRAS water-soluble EMIQ (enzymatically modified isoquercitrin), and Ashland Inc. with Quercevital delivery matrices. Industrial-scale Sophora japonica rutin hydrolysis and 95% to 98% quercetin dihydrate crystallization are anchored by Layn Natural Ingredients, Sabinsa Corporation, Arjuna Natural Pvt. Ltd. (June 2026), and Botanic Healthcare. Meanwhile, Givaudan SA (July 2026), International Flavors & Fragrances Inc. (November 2026), and Kemin Industries integrate standardized quercetin and onion polyphenols into functional beverages and clean-label food preservation systems.

What Matters When a Buyer Selects a Quercetin Supplier?

Supplement quality directors and contract encapsulators evaluate suppliers on batch-level HPLC purity certificates confirming at least 95.0% quercetin dihydrate (or 34.0% to 42.0% active quercetin in phytosome dispersions) with unreacted residual rutin capped below 2.0%. Procurement teams also require USP dietary supplement monograph compliance, polycyclic aromatic hydrocarbon (PAH4) screening on dried flower buds aligned with World Health Organization (October 2025) herbal quality frameworks, and published human pharmacokinetic or cohort evidence such as the hyperuricemia trials in Frontiers in Nutrition (February 2025).

Which Capabilities Distinguish Product Offers?

Supplier differentiation centers on aqueous dispersibility, clinical dossier depth, and botanical circularity. Indena S.p.A. (July 2026) backs QUERCEFIT with over ten human clinical studies across senolytic aging, respiratory comfort, and sports recovery, achieving 20-fold higher bioabsorption via sunflower-lecithin dispersion. San-Ei Gen F.F.I. enables clear ready-to-drink beverages through enzymatic alpha-glycosylation (EMIQ), whereas Layn Natural Ingredients and Arjuna Natural Pvt. Ltd. compete on vertically integrated agronomy, solar-powered cGMP extraction, and customizable 80-mesh to 200-mesh particle distributions.

How Does Geographic Reach Affect Competition?

Raw Sophora japonica flower-bud harvesting and primary rutin acid hydrolysis remain concentrated in China and Vietnam under Layn Natural Ingredients, complemented by cGMP botanical refineries in India operated by Sabinsa Corporation, Arjuna Natural Pvt. Ltd., and Botanic Healthcare. Conversely, value-added phospholipid complexation, glycosylation, and finished beverage/supplement application laboratories are anchored in Italy, Switzerland, Japan, and the United States by Indena S.p.A., Givaudan SA, San-Ei Gen F.F.I., Ashland Inc., and Kemin Industries, allowing local regulatory and formulation support in Western markets.

Table 4: Quercetin Market Company Developments and Commercial Implications (2025 to 2026)
Verified Company Evidence (2025 to 2026) Commercial Effect Buyer Action
28 October 2026: Indena S.p.A. exhibitiond QUERCEFIT senolytic cellular-aging innovations under its Golden Aging platform at SupplySide Global 2026 (Indena S.p.A., October 2026). Positions sunflower-lecithin Quercetin Phytosome (20x bioabsorption) for compact 250 mg daily longevity capsules. Formulate single-capsule senolytic stacks pairing Quercetin Phytosome with fisetin or NAD+ precursors.
23 July 2026: Givaudan SA reported H1 2026 Group sales of CHF 3,799 million (+3.6% LFL) and Taste & Wellbeing sales of CHF 1,789 million (Givaudan SA, July 2026). Reinforces multinational investment in botanical flavonoid extracts and natural taste-masking systems across regional hubs. Pair water-dispersible quercetin with natural bitterness modulators in functional beverages and gummies.
23 June 2026: Arjuna Natural Pvt. Ltd. presented its standardized botanical flavonoid and polyphenol portfolio at Nutriform Business Days 2026 in France (Arjuna Natural Pvt. Ltd., June 2026). Expands direct cGMP Indian botanical extraction partnerships with European parapharmacy supplement finishers. Qualify secondary cGMP Sophora japonica extractors to diversify Asian raw-material sourcing.
7 February 2025: An observational study of three cohorts in Frontiers in Nutrition reported uric acid and triglyceride changes after 90 days of supplementation supplying 400 mg/day quercetin delivered as 1,000 mg/day Quercetin Phytosome (Frontiers in Nutrition, February 2025). Substantiates 13.1% to 15.2% serum uric-acid reduction and 10.2% to 20.8% triglyceride reduction in human cohorts. Extend quercetin supplement positioning from seasonal pollen relief into year-round metabolic health.

Source: Verified corporate disclosures and Future Market Insights analysis, 2026.

Table 5: Quercetin Market Representative Company Overview
Company Core Positioning Verified Activity & Source Attribution
Indena S.p.A. Italian botanical active leader producing QUERCEFIT (Quercetin Indena Phytosome) standardized to 34% to 42% quercetin Presented QUERCEFIT at in-Vitality 2025 in Milan (Indena S.p.A., November 2025) and spotlighted Golden Aging longevity science at SupplySide Global 2026 (Indena S.p.A., October 2026).
Layn Natural Ingredients Vertically integrated Chinese extractor of Sophora japonica rutin and 95% to 98% quercetin dihydrate crystals Operates cGMP Sophora japonica agronomy and acid-hydrolysis refineries supplying North American, European, and Asian supplement brands.
Sabinsa Corporation Global phyto-extraction manufacturer of standardized 95% Sophora japonica quercetin dihydrate Maintains US, Indian, and European cGMP botanical supply and batch-level HPTLC/HPLC verification for practitioner and retail immunity lines.
San-Ei Gen F.F.I. Japanese pioneer of FDA GRAS water-soluble EMIQ (enzymatically modified isoquercitrin) Supplies alpha-glycosyl isoquercitrin with up to 40-fold higher peak plasma absorption for clear functional drinks and sports hydration (Frontiers in Nutrition, February 2026).
Ashland Inc. Global specialty life-sciences supplier of Quercevital bioavailable quercetin delivery systems Engineers enhanced-solubility nutraceutical delivery matrices and tablet compression binders for North American and European contract finishers.
Givaudan SA Global Taste & Wellbeing and Naturex supplier of standardized quercetin and onion polyphenol extracts Reported H1 2026 Group sales of CHF 3,799 million and Taste & Wellbeing sales of CHF 1,789 million while expanding sites in Mexico and Indonesia (Givaudan SA, July 2026).
International Flavors & Fragrances Inc. (IFF) Global Health & Biosciences supplier of botanical flavonoid extracts and beverage modulators Reported Q3 2026 financial results in November 2026 (International Flavors & Fragrances Inc., November 2026) alongside its botanical unit transition to SuanNutra.
Kemin Industries Global manufacturer of plant-derived polyphenol and flavonoid antioxidant shelf-life and nutrition systems Supplies clean-label botanical antioxidant blends to delay lipid oxidation in packaged meats, oils, and nutritional powders.
Arjuna Natural Pvt. Ltd. Indian solar-powered cGMP botanical extractor exporting standardized flavonoid extracts to 70+ countries Showcased clinically researched botanical flavonoid ingredients at Nutriform Business Days 2026 in France (Arjuna Natural Pvt. Ltd., June 2026).
Botanic Healthcare Indian cGMP manufacturer and exporter of USP-grade Sophora japonica quercetin dihydrate powders Supplies 95% to 98% standardized quercetin dihydrate drums for capsule and tablet co-packers across North America, Europe, and Asia.

Source: Verified corporate disclosures and Future Market Insights analysis, 2026.

Quercetin Market Report Scope and Research Methodology

FMI sizes the global quercetin market by reconciling processed botanical biomass (64.2 thousand to 72.0 thousand metric tons of Sophora japonica flower buds and Allium cepa skins in 2026) and refined active volume (5,640 to 6,260 metric tons in 2026) against grade-weighted wholesale realizations across 95% to 98% quercetin dihydrate crystals, sunflower-lecithin phytosomes, and enzymatically modified isoquercitrin (EMIQ). Top-down flavonoid and natural-antioxidant industry benchmarks are cross-checked against bottom-up encapsulation line expenditure and validated through primary interviews with Sophora japonica rutin hydrolysis directors, phospholipid formulation chemists, and supplement brand procurement leads. Country revenue is recorded where the finished supplement, beverage, or food product is consumed, with all segment and country figures reconciling to the global total. Corporate disclosures are used strictly to verify product launches, clinical dossiers, and manufacturing footprints rather than to estimate proprietary company revenues.

Table 6: Quercetin Market Report Scope
Coverage Field Report Scope
Market definition Commercial B2B supplier revenue from purified quercetin dihydrate (CAS 6151-25-3), anhydrous quercetin (CAS 117-39-5), phospholipid-complexed quercetin phytosomes, and enzymatically modified isoquercitrin (EMIQ).
Botanical sources Sophora japonica Japanese Pagoda Tree Flower Buds, Yellow Onion Allium cepa Skins, Apple Fruit Peels, and Dimorphandra mollis Fava d'Anta Pods.
Chemical formulations Quercetin Dihydrate Crystalline Powder Above 95%, Quercetin Phytosome Phospholipid Complex Liposomal, Enzymatically Modified Isoquercitrin EMIQ, and Water-Dispersible Cyclodextrin Inclusion Complexes.
Health targets Respiratory Allergy Mast Cell Histamine Stabilization, Immune Defense and Cellular Senolytic Formulations, Cardiovascular Endothelial Blood Pressure Support, Sports Endurance Athletic Performance, and Metabolic Uric Acid and Glycemic Support.
Delivery formats Vegetarian Two-Piece Hard Capsules, Compressed Sustained-Release Tablets, Effervescent and Functional Beverage Powders, and Pectin Gummies and Liquid Emulsions.
Sales channels Direct to Nutraceutical and Supplement Brands, Specialty Botanical Ingredient Distributors, Contract Nutraceutical Co-Packers, and B2B Digital Ingredient Marketplaces.
Ingredients included Acid- or enzymatically hydrolyzed quercetin dihydrate (95% to 98% HPLC), sunflower-lecithin Quercetin Phytosome (34% to 42% HPLC), and alpha-glycosyl isoquercitrin (EMIQ).
Exclusions Unhydrolyzed bulk rutin sold standalone, synthetic pharmaceutical small-molecule drugs, and unstandardized fruit or vegetable juice powders.
Quantitative units USD million for revenue valuation; metric tons for refined active flavonol volume.
Volume basis Refined quercetin dihydrate, anhydrous aglycone, phytosome, and EMIQ commercial tonnage.
Value basis B2B ingredient revenue counted in the country where finished supplements, functional beverages, or clean-label foods are consumed.
Regions covered North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.
National coverage United States, Germany, United Kingdom, France, Canada, Brazil, Spain, Mexico, and regional rest-of-world clusters.
Companies covered Indena S.p.A., Layn Natural Ingredients, Sabinsa Corporation, San-Ei Gen F.F.I., Ashland Inc., Givaudan SA, International Flavors & Fragrances Inc. (IFF), Kemin Industries, Arjuna Natural Pvt. Ltd., and Botanic Healthcare.

Source: Future Market Insights analysis of the quercetin market, 2026.

Research Sources and Bibliography

  • Applied Sciences. (2025, July 9). Quercetin-Fortified Animal Forage from Onion Waste: A Zero-Waste Approach to Bioactive Feed Development. https://www.mdpi.com/2076-3417/15/14/7694
  • Arjuna Natural Pvt. Ltd. (2026, June 23). At Nutriform Business Days 2026: Showcasing Clinically Researched Botanical Ingredients. https://arjunanatural.com/at-nutriform-business-days-2026/
  • Chemistry Proceedings. (2025, November 12). Understanding the Therapeutic Potential of Quercetin and Resveratrol: Computational Insights into Antidiabetic Activity. https://www.mdpi.com/2673-4583/18/1/53
  • Frontiers in Endocrinology. (2026, April 13). Quercetin in metabolic diseases: mechanisms, therapeutics, and multidimensional frontiers. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1800322/full
  • Frontiers in Nutrition. (2025, February 7). Potential pharmacological effect of Quercetin Phytosome in the management of hyperuricemia: results from real-life clinical studies. https://pubmed.ncbi.nlm.nih.gov/39990611/
  • Frontiers in Nutrition. (2026, February 18). The multi-target protective effects of quercetin in cerebrovascular diseases: a dietary strategy for endothelial repair and neuroprotection. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1775964/full
  • Frontiers in Pharmacology. (2026, February 26). Recent developments in quercetin nanomedicine and applications in osteoarthritis and rheumatoid arthritis therapies. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1790233/full
  • Frontiers in Pharmacology. (2026, June 10). Quercetin as a multitarget neuroprotective agent against cerebral ischaemia-reperfusion injury: mechanisms and therapeutic potential. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1860351/full
  • Givaudan SA. (2026, July 23). 2026 Half-year results: Sustained solid performance. https://www.givaudan.com/media/media-releases/2026/2026-half-year-results
  • Indena S.p.A. (2025, November 19). From ache management to healthy aging: Indena addresses today's urgent health needs with innovative natural solutions, at in-Vitality 2025. https://www.indena.com/press-release/from-ache-management-to-healthy-aging-indena-addresses-todays-urgent-health-needs-with-innovative-natural-solutions-at-in-vitality-2025/
  • Indena S.p.A. (2025, December 2). QUERCEFIT Quercetin Phytosome: Hit the mark to slow down cell aging. https://www.indena.com/adv-campaign/quercefit-inflammation-adv-2/
  • Indena S.p.A. (2026, July 15). QUERCEFIT Nutraceutical Quercetin Indena Phytosome Specification Sheet. https://www.indena.com/indena_files/2026/07/quercefit_ss_us.pdf
  • Indena S.p.A. (2026, October 28). The Golden Aging revolution: how Indena's botanical innovations redefine longevity and healthy appearance at SupplySide Global 2026. https://www.indena.com/press-release/the-golden-aging-revolution-how-indenas-botanical-innovations-redefine-longevity-and-healthy-appearance-at-supplyside-global-2026/
  • International Flavors & Fragrances Inc. (2026, November 4). IFF Reports Third Quarter 2026 Results. https://ir.iff.com/news-releases/news-release-details/iff-reports-third-quarter-2026-results
  • Molecules. (2025, July 24). Potential of Quercetin as a Promising Therapeutic Agent Against Type 2 Diabetes. https://www.mdpi.com/1420-3049/30/15/3096
  • Molecules. (2026, August 12). Quercetin: Mechanisms of Action, Clinical Evidence in Metabolic Syndrome, and Translational Opportunities in Food Preservation. https://www.mdpi.com/1420-3049/31/16/2810
  • National Center for Biotechnology Information. (2026, May 27). A Review of the Potential Therapeutic Benefits of Quercetin for Uterine-Related Conditions. https://pmc.ncbi.nlm.nih.gov/articles/PMC13295906/
  • USDA Foreign Agricultural Service. (2026, March 24). United Kingdom: Food Processing Ingredients Annual (Report UK2026-0008). https://www.fas.usda.gov/data/gain/2026/03/united-kingdom-food-processing-ingredients-annual
  • USDA Foreign Agricultural Service. (2026, March 31). Brazil: Food Processing Ingredients Annual (Report BR2026-0011). https://www.fas.usda.gov/data/gain/2026/03/brazil-food-processing-ingredients-annual
  • USDA Foreign Agricultural Service. (2026, March 31). Spain: Food Processing Ingredients Annual (Report SP2026-0003). https://www.fas.usda.gov/data/gain/2026/03/spain-food-processing-ingredients-annual
  • USDA Foreign Agricultural Service. (2026, April 3). France: Food Processing Ingredients Annual (Report FR2026-0003). https://www.fas.usda.gov/data/gain/2026/04/france-food-processing-ingredients-annual
  • USDA Foreign Agricultural Service. (2026, April 6). Mexico: Food Processing Ingredients Annual (Report MX2026-0022). https://www.fas.usda.gov/data/gain/2026/04/mexico-food-processing-ingredients-annual
  • USDA Foreign Agricultural Service. (2026, August 27). Canada: Food Processing Ingredients Annual (Report CA2026-0022). https://www.fas.usda.gov/data/gain/2026/08/canada-food-processing-ingredients-annual
  • World Health Organization. (2025, October 30). Global traditional medicine strategy 2025-2034 (ISBN 978-92-4-011317-6). https://www.who.int/publications/i/item/9789240113176

Table of Content

  1. Key Takeaways
    • Market Size and CAGR
    • Top Growth Driver
    • Fastest Growing Segment
    • Leading Region
    • Key Companies
    • Emerging Opportunities
  2. Executive Summary
    • Global Market Outlook
    • Demand-side Trends
    • Supply-side Trends
    • Technology Roadmap Analysis
    • Analysis and Recommendations
    • Analyst Perspective (What is happening? Why now? What should investors know?)
    • Key Questions Answered
      • How large is the market?
      • What is the CAGR?
      • What are key trends?
      • Which region dominates?
      • Who are the leaders?
Read More...
  1. Market Overview
    • Market Coverage / Taxonomy
    • Market Definition / Scope / Limitations
  2. Research Methodology
    • Chapter Orientation
    • Analytical Lens and Working Hypotheses
      • Market Structure, Signals, and Trend Drivers
      • Benchmarking and Cross-market Comparability
      • Market Sizing, Forecasting, and Opportunity Mapping
    • Research Design and Evidence Framework
      • Desk Research Programme (Secondary Evidence)
      • Expert Input and Fieldwork (Primary Evidence)
      • Tooling, Models, and Reference Databases
    • Data Engineering and Model Build
    • Quality Assurance and Audit Trail
  3. Market Background
    • Market Dynamics (Drivers, Restraints, Opportunity, Trends)
    • Scenario Forecast (Optimistic, Likely, Conservative)
    • Impact Analysis
      • AI Impact
      • Sustainability Impact
      • Regulatory Impact
      • Technology Impact
    • Consumer / Buyer Analysis
      • Purchase Drivers
      • Adoption Barriers
      • Buyer Journey
    • Opportunity Map Analysis
    • Product Life Cycle Analysis
    • Supply Chain Analysis
    • Investment Feasibility Matrix
    • Value Chain Analysis
    • PESTLE and Porter's Analysis
    • Regulatory Landscape
    • Regional Parent Market Outlook
    • Production and Consumption Statistics
    • Import and Export Statistics
  4. Global Market Analysis and Forecast, 2021 to 2036
    • Historical Market Size Value (USD Million) Analysis, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Projections, 2026 to 2036
      • Y-o-Y Growth Trend Analysis
      • Absolute $ Opportunity Analysis
  5. Global Market Pricing Analysis, 2021 to 2036
  6. Global Market Analysis and Forecast, By Botanical Source, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Botanical Source, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Botanical Source, 2026 to 2036
      • Sophora japonica Japanese Pagoda Tree Flower Buds
      • Yellow Onion Allium cepa Skins
      • Apple Fruit Peels
      • Dimorphandra mollis Fava d'Anta Pods
    • Y-o-Y Growth Trend Analysis By Botanical Source, 2021 to 2025
    • Absolute $ Opportunity Analysis By Botanical Source, 2026 to 2036
  7. Global Market Analysis and Forecast, By Chemical Formulation, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Chemical Formulation, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Chemical Formulation, 2026 to 2036
      • Quercetin Dihydrate Crystalline Powder Above 95%
      • Quercetin Phytosome Phospholipid Complex Liposomal
      • Enzymatically Modified Isoquercitrin EMIQ
      • Water-Dispersible Cyclodextrin Inclusion Complexes
    • Y-o-Y Growth Trend Analysis By Chemical Formulation, 2021 to 2025
    • Absolute $ Opportunity Analysis By Chemical Formulation, 2026 to 2036
  8. Global Market Analysis and Forecast, By Health Target, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Health Target, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Health Target, 2026 to 2036
      • Respiratory Allergy Mast Cell Histamine Stabilization
      • Immune Defense and Cellular Senolytic Formulations
      • Cardiovascular Endothelial Blood Pressure Support
      • Sports Endurance Athletic Performance
      • Metabolic Uric Acid and Glycemic Support
    • Y-o-Y Growth Trend Analysis By Health Target, 2021 to 2025
    • Absolute $ Opportunity Analysis By Health Target, 2026 to 2036
  9. Global Market Analysis and Forecast, By Delivery Format, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Delivery Format, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Delivery Format, 2026 to 2036
      • Vegetarian Two-Piece Hard Capsules
      • Compressed Sustained-Release Tablets
      • Effervescent and Functional Beverage Powders
      • Pectin Gummies and Liquid Emulsions
    • Y-o-Y Growth Trend Analysis By Delivery Format, 2021 to 2025
    • Absolute $ Opportunity Analysis By Delivery Format, 2026 to 2036
  10. Global Market Analysis and Forecast, By Sales Channel, 2021 to 2036
    • Introduction / Key Findings
    • Historical Market Size Value (USD Million) Analysis By Sales Channel, 2021 to 2025
    • Current and Future Market Size Value (USD Million) Analysis and Forecast By Sales Channel, 2026 to 2036
      • Direct to Nutraceutical and Supplement Brands
      • Specialty Botanical Ingredient Distributors
      • Contract Nutraceutical Co-Packers
      • B2B Digital Ingredient Marketplaces
    • Y-o-Y Growth Trend Analysis By Sales Channel, 2021 to 2025
    • Absolute $ Opportunity Analysis By Sales Channel, 2026 to 2036
  11. Global Market Analysis and Forecast, By Region, 2021 to 2036
    • Introduction
    • Historical Market Size Value (USD Million) Analysis By Region, 2021 to 2025
    • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2026 to 2036
      • North America
      • Latin America
      • Western Europe
    • Market Attractiveness Analysis By Region
  12. North America Market Analysis and Forecast, By Country, 2021 to 2036
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • United States
        • Canada
      • By Botanical Source
      • By Chemical Formulation
      • By Health Target
      • By Delivery Format
      • By Sales Channel
    • Market Attractiveness Analysis
      • By Country
      • By Botanical Source
      • By Chemical Formulation
      • By Health Target
      • By Delivery Format
      • By Sales Channel
    • Key Takeaways
  13. Latin America Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Brazil
        • Mexico
      • By Botanical Source
      • By Chemical Formulation
      • By Health Target
      • By Delivery Format
      • By Sales Channel
    • Market Attractiveness Analysis
      • By Country
      • By Botanical Source
      • By Chemical Formulation
      • By Health Target
      • By Delivery Format
      • By Sales Channel
    • Key Takeaways
  14. Western Europe Market Analysis and Forecast, By Country
    • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2021 to 2025
    • Market Size Value (USD Million) Forecast By Market Taxonomy, 2026 to 2036
      • By Country
        • Germany
        • United Kingdom
        • France
        • Spain
      • By Botanical Source
      • By Chemical Formulation
      • By Health Target
      • By Delivery Format
      • By Sales Channel
    • Market Attractiveness Analysis
      • By Country
      • By Botanical Source
      • By Chemical Formulation
      • By Health Target
      • By Delivery Format
      • By Sales Channel
    • Key Takeaways
  15. Key Countries Market Analysis
    • United States
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Botanical Source
        • By Chemical Formulation
        • By Health Target
        • By Delivery Format
        • By Sales Channel
    • Germany
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Botanical Source
        • By Chemical Formulation
        • By Health Target
        • By Delivery Format
        • By Sales Channel
    • United Kingdom
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Botanical Source
        • By Chemical Formulation
        • By Health Target
        • By Delivery Format
        • By Sales Channel
    • France
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Botanical Source
        • By Chemical Formulation
        • By Health Target
        • By Delivery Format
        • By Sales Channel
    • Canada
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Botanical Source
        • By Chemical Formulation
        • By Health Target
        • By Delivery Format
        • By Sales Channel
    • Brazil
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Botanical Source
        • By Chemical Formulation
        • By Health Target
        • By Delivery Format
        • By Sales Channel
    • Spain
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Botanical Source
        • By Chemical Formulation
        • By Health Target
        • By Delivery Format
        • By Sales Channel
    • Mexico
      • Pricing Analysis
      • Market Share Analysis, 2025
        • By Botanical Source
        • By Chemical Formulation
        • By Health Target
        • By Delivery Format
        • By Sales Channel
  16. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Botanical Source
      • By Chemical Formulation
      • By Health Target
      • By Delivery Format
      • By Sales Channel
      • Emerging Startups
      • Innovation Benchmarking
    • Competition Analysis
      • Competition Deep Dive
        • Indena S.p.A.
          • Overview
          • Product Portfolio
          • Profitability by Market Segments
          • Sales Footprint
          • Strategy Overview
            • Marketing Strategy
            • Product Strategy
            • Channel Strategy
        • Layn Natural Ingredients
        • Sabinsa Corporation
        • San-Ei Gen F.F.I.
        • Ashland Inc.
        • Givaudan SA
        • International Flavors & Fragrances Inc. (IFF)
        • Kemin Industries
        • Arjuna Natural Pvt. Ltd.
        • Botanic Healthcare
      • Case Studies
      • Success Stories
      • Recent Developments
  17. Assumptions & Acronyms Used

List of Tables

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2021 to 2036
  • Table 2: Global Market Value (USD Million) Forecast by Botanical Source, 2021 to 2036
  • Table 3: Global Market Value (USD Million) Forecast by Chemical Formulation, 2021 to 2036
  • Table 4: Global Market Value (USD Million) Forecast by Health Target, 2021 to 2036
  • Table 5: Global Market Value (USD Million) Forecast by Delivery Format, 2021 to 2036
  • Table 6: Global Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036
  • Table 7: North America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 8: North America Market Value (USD Million) Forecast by Botanical Source, 2021 to 2036
  • Table 9: North America Market Value (USD Million) Forecast by Chemical Formulation, 2021 to 2036
  • Table 10: North America Market Value (USD Million) Forecast by Health Target, 2021 to 2036
  • Table 11: North America Market Value (USD Million) Forecast by Delivery Format, 2021 to 2036
  • Table 12: North America Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036
  • Table 13: Latin America Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 14: Latin America Market Value (USD Million) Forecast by Botanical Source, 2021 to 2036
  • Table 15: Latin America Market Value (USD Million) Forecast by Chemical Formulation, 2021 to 2036
  • Table 16: Latin America Market Value (USD Million) Forecast by Health Target, 2021 to 2036
  • Table 17: Latin America Market Value (USD Million) Forecast by Delivery Format, 2021 to 2036
  • Table 18: Latin America Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036
  • Table 19: Western Europe Market Value (USD Million) Forecast by Country, 2021 to 2036
  • Table 20: Western Europe Market Value (USD Million) Forecast by Botanical Source, 2021 to 2036
  • Table 21: Western Europe Market Value (USD Million) Forecast by Chemical Formulation, 2021 to 2036
  • Table 22: Western Europe Market Value (USD Million) Forecast by Health Target, 2021 to 2036
  • Table 23: Western Europe Market Value (USD Million) Forecast by Delivery Format, 2021 to 2036
  • Table 24: Western Europe Market Value (USD Million) Forecast by Sales Channel, 2021 to 2036

List of Figures

  • Figure 1: Global Market Pricing Analysis
  • Figure 2: Global Market Value (USD Million) Forecast 2021-2036
  • Figure 3: Global Market Value Share and BPS Analysis by Botanical Source, 2026 and 2036
  • Figure 4: Global Market Y-o-Y Growth Comparison by Botanical Source, 2026-2036
  • Figure 5: Global Market Attractiveness Analysis by Botanical Source
  • Figure 6: Global Market Value Share and BPS Analysis by Chemical Formulation, 2026 and 2036
  • Figure 7: Global Market Y-o-Y Growth Comparison by Chemical Formulation, 2026-2036
  • Figure 8: Global Market Attractiveness Analysis by Chemical Formulation
  • Figure 9: Global Market Value Share and BPS Analysis by Health Target, 2026 and 2036
  • Figure 10: Global Market Y-o-Y Growth Comparison by Health Target, 2026-2036
  • Figure 11: Global Market Attractiveness Analysis by Health Target
  • Figure 12: Global Market Value Share and BPS Analysis by Delivery Format, 2026 and 2036
  • Figure 13: Global Market Y-o-Y Growth Comparison by Delivery Format, 2026-2036
  • Figure 14: Global Market Attractiveness Analysis by Delivery Format
  • Figure 15: Global Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 16: Global Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 17: Global Market Attractiveness Analysis by Sales Channel
  • Figure 18: Global Market Value (USD Million) Share and BPS Analysis by Region, 2026 and 2036
  • Figure 19: Global Market Y-o-Y Growth Comparison by Region, 2026-2036
  • Figure 20: Global Market Attractiveness Analysis by Region
  • Figure 21: North America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 22: Latin America Market Incremental Dollar Opportunity, 2026-2036
  • Figure 23: Western Europe Market Incremental Dollar Opportunity, 2026-2036
  • Figure 24: North America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 25: North America Market Value Share and BPS Analysis by Botanical Source, 2026 and 2036
  • Figure 26: North America Market Y-o-Y Growth Comparison by Botanical Source, 2026-2036
  • Figure 27: North America Market Attractiveness Analysis by Botanical Source
  • Figure 28: North America Market Value Share and BPS Analysis by Chemical Formulation, 2026 and 2036
  • Figure 29: North America Market Y-o-Y Growth Comparison by Chemical Formulation, 2026-2036
  • Figure 30: North America Market Attractiveness Analysis by Chemical Formulation
  • Figure 31: North America Market Value Share and BPS Analysis by Health Target, 2026 and 2036
  • Figure 32: North America Market Y-o-Y Growth Comparison by Health Target, 2026-2036
  • Figure 33: North America Market Attractiveness Analysis by Health Target
  • Figure 34: North America Market Value Share and BPS Analysis by Delivery Format, 2026 and 2036
  • Figure 35: North America Market Y-o-Y Growth Comparison by Delivery Format, 2026-2036
  • Figure 36: North America Market Attractiveness Analysis by Delivery Format
  • Figure 37: North America Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 38: North America Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 39: North America Market Attractiveness Analysis by Sales Channel
  • Figure 40: Latin America Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 41: Latin America Market Value Share and BPS Analysis by Botanical Source, 2026 and 2036
  • Figure 42: Latin America Market Y-o-Y Growth Comparison by Botanical Source, 2026-2036
  • Figure 43: Latin America Market Attractiveness Analysis by Botanical Source
  • Figure 44: Latin America Market Value Share and BPS Analysis by Chemical Formulation, 2026 and 2036
  • Figure 45: Latin America Market Y-o-Y Growth Comparison by Chemical Formulation, 2026-2036
  • Figure 46: Latin America Market Attractiveness Analysis by Chemical Formulation
  • Figure 47: Latin America Market Value Share and BPS Analysis by Health Target, 2026 and 2036
  • Figure 48: Latin America Market Y-o-Y Growth Comparison by Health Target, 2026-2036
  • Figure 49: Latin America Market Attractiveness Analysis by Health Target
  • Figure 50: Latin America Market Value Share and BPS Analysis by Delivery Format, 2026 and 2036
  • Figure 51: Latin America Market Y-o-Y Growth Comparison by Delivery Format, 2026-2036
  • Figure 52: Latin America Market Attractiveness Analysis by Delivery Format
  • Figure 53: Latin America Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 54: Latin America Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 55: Latin America Market Attractiveness Analysis by Sales Channel
  • Figure 56: Western Europe Market Value Share and BPS Analysis by Country, 2026 and 2036
  • Figure 57: Western Europe Market Value Share and BPS Analysis by Botanical Source, 2026 and 2036
  • Figure 58: Western Europe Market Y-o-Y Growth Comparison by Botanical Source, 2026-2036
  • Figure 59: Western Europe Market Attractiveness Analysis by Botanical Source
  • Figure 60: Western Europe Market Value Share and BPS Analysis by Chemical Formulation, 2026 and 2036
  • Figure 61: Western Europe Market Y-o-Y Growth Comparison by Chemical Formulation, 2026-2036
  • Figure 62: Western Europe Market Attractiveness Analysis by Chemical Formulation
  • Figure 63: Western Europe Market Value Share and BPS Analysis by Health Target, 2026 and 2036
  • Figure 64: Western Europe Market Y-o-Y Growth Comparison by Health Target, 2026-2036
  • Figure 65: Western Europe Market Attractiveness Analysis by Health Target
  • Figure 66: Western Europe Market Value Share and BPS Analysis by Delivery Format, 2026 and 2036
  • Figure 67: Western Europe Market Y-o-Y Growth Comparison by Delivery Format, 2026-2036
  • Figure 68: Western Europe Market Attractiveness Analysis by Delivery Format
  • Figure 69: Western Europe Market Value Share and BPS Analysis by Sales Channel, 2026 and 2036
  • Figure 70: Western Europe Market Y-o-Y Growth Comparison by Sales Channel, 2026-2036
  • Figure 71: Western Europe Market Attractiveness Analysis by Sales Channel
  • Figure 72: Global Market - Tier Structure Analysis
  • Figure 73: Global Market - Company Share Analysis

Frequently Asked Questions

How big is the quercetin market in 2026?

Future Market Insights estimates the global quercetin market at USD 479.7 million in 2026, rising from USD 463.0 million in 2025 on steady demand for respiratory-allergy, senolytic, and metabolic supplements.

How fast is the quercetin market expected to grow through 2036?

FMI projects the market to grow at a 3.8% CAGR from 2026 to 2036, reaching USD 696.5 million by 2036 and generating USD 216.8 million in incremental revenue over the 10-year forecast window.

Which botanical source leads the quercetin market?

Sophora japonica Japanese Pagoda Tree Flower Buds lead with 47.4% of 2026 revenue because dried unopened buds contain 15% to 25% rutin for cost-efficient acid hydrolysis into quercetin.

Which chemical formulation and delivery format lead the quercetin market?

Quercetin Dihydrate Crystalline Powder Above 95% captures 51.1% of chemical formulation revenue in 2026, while Vegetarian Two-Piece Hard Capsules lead delivery formats at 44.2% share.

Which health target accounts for the largest share of quercetin demand?

Respiratory Allergy Mast Cell Histamine Stabilization holds 46.5% of 2026 revenue, driven by repeat consumer purchasing of non-drowsy seasonal pollen and sinus support combinations.

Which sales channel dominates B2B quercetin distribution?

Direct to Nutraceutical and Supplement Brands commands 56.8% of 2026 sales through direct Sophora japonica harvest contracting, HPLC purity audits, and clinical phytosome trademark licensing.

Which country is the largest quercetin market globally?

The United States is the largest national market, accounting for 31.0% of global revenue in 2026 (USD 148.7 million) and projected to reach USD 226.6 million by 2036 (4.3% CAGR), followed by Germany at 10.0% (USD 48.0 million).

Which countries are projected to grow fastest from 2026 to 2036?

Mexico leads national growth at a 4.6% CAGR (USD 14.4 million to USD 22.6 million), followed by the United States at a 4.3% CAGR (USD 148.7 million to USD 226.6 million) and Germany at 4.1%.

Preview the report firsthand - request a free sample

Get Sample

Get the brochure for pricing and purchase details.